"This house believes that therapeutic substitution of proton pump inhibitors is an unethical way to cut healthcare costs".
The motion: "This house believes that therapeutic substitution of proton pump inhibitors is an unethical way to cut healthcare costs".
Find out next week what MBiotech students think!
For the motion: Team MedIntel
Against the motion: Team Aithon
Hosts: Inno5
Tuesday, March 26th, 2013, 6.30pm-8.00pm. Instructional Centre, Room 120. Open to the public.
The Master of Biotechnology Program would like to thank AstraZeneca Canada Inc. for their continued support of this seminar series